2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside alleviated the acute hepatotoxicity and DNA damage in diethylnitrosamine-contaminated mice

Life Sci. 2020 Feb 15:243:117274. doi: 10.1016/j.lfs.2020.117274. Epub 2020 Jan 9.

Abstract

Aims: 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside (TSG) is the key bioactive ingredient extracted from Polygonum multiflorum Thumb. Pharmacological studies suggest that it exerts numerous biological effects, including anti-oxidant, anti-aging, and anti-inflammation. This study aimed at investigating the effect of TSG on diethylnitrosamine (DEN)-induced acute hepatotoxicity and DNA damage.

Main methods: Fifty male C57BL/6 mice were randomly divided into 5 groups (n = 10 each): control, DEN, DEN+TSG (low), DEN+TSG (high) and TSG (high) groups. DEN (100 mg/kg) was injected intraperitoneally (i.p.) alone or with TSG (30 or 60 mg/kg, i.p.) for 5 consecutive days.

Key findings: TSG inhibited liver injury and inflammatory cell infiltration in DEN-treated mice. It also attenuated DEN-induced accumulation of reactive oxygen species (ROS), proinflammatory cytokines, and DNA damage. Moreover, TSG promoted the expression of nuclear erythroid 2-related factor 2 (Nrf2) target antioxidant genes by enhancing Nrf2 protein phosphorylation and nuclear translocation. As major phase I detoxification enzymes, cytochrome P450 family 2 subfamily E member 1 (CYP2E1) and cytochrome P450 1 subfamily A member 1 (CYP1A1) are responsible for the metabolic activation of DEN. We found that TSG administration inhibited CYP2E1 and CYP1A1 induction in DEN-treated mice.

Significance: These results indicate that TSG can alleviate DEN-induced acute hepatotoxicity by modulating the Nrf2-related antioxidant system and metabolic activation of DEN. Therefore, TSG might be a promising medication for DEN-induced liver injury treatment.

Keywords: DEN; DNA damage; Hepatotoxicity; Inflammation; Nrf2; Oxidative stress; TSG.

MeSH terms

  • Alkylating Agents / toxicity*
  • Animals
  • Cytochrome P-450 CYP1A1 / metabolism
  • Cytochrome P-450 CYP2E1 / metabolism
  • Cytokines / metabolism
  • DNA Damage*
  • Diethylnitrosamine / administration & dosage
  • Diethylnitrosamine / toxicity*
  • Dose-Response Relationship, Drug
  • Glucosides / administration & dosage
  • Glucosides / pharmacology*
  • Inflammation Mediators / metabolism
  • Liver / drug effects*
  • Liver / enzymology
  • Liver / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Oxidative Stress / drug effects
  • Stilbenes / administration & dosage
  • Stilbenes / pharmacology*

Substances

  • Alkylating Agents
  • Cytokines
  • Glucosides
  • Inflammation Mediators
  • Stilbenes
  • 2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside
  • Diethylnitrosamine
  • Cytochrome P-450 CYP2E1
  • cytochrome P-450 2E1, mouse
  • Cyp1a1 protein, mouse
  • Cytochrome P-450 CYP1A1